CHIL became one of the first five companies worldwide to manufacture COVID-19 antigen tests, reinforcing its pioneering position in rapid diagnostics.
In the same year:
- The Belarus Ministry of Health formally acknowledged product quality through an official letter of appreciation.
- Approval from the German PEI Institute was obtained, and CHIL products were included in the BfArM list.
- A clinical study conducted in Japan confirmed the 100% accuracy of CHIL’s COVID-19 products, and the results were published in a scientific article.
In February 2020, CHIL participated in Medlab Middle East, Dubai.
In November 2020, CHIL participated in MEDICA Messe Düsseldorf, Düsseldorf.